{{Rsnum
|rsid=7709212
|Gene=FBXO44
|Chromosome=5
|position=159337169
|Orientation=plus
|GMAF=0.393
|Gene_s=FBXO44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 46.0 | 45.1
| HCB | 16.8 | 51.1 | 32.1
| JPT | 26.5 | 45.1 | 28.3
| YRI | 6.8 | 38.1 | 55.1
| ASW | 8.8 | 35.1 | 56.1
| CHB | 16.8 | 51.1 | 32.1
| CHD | 20.2 | 51.9 | 27.9
| GIH | 15.8 | 45.5 | 38.6
| LWK | 15.5 | 49.1 | 35.5
| MEX | 36.2 | 41.4 | 22.4
| MKK | 9.0 | 48.1 | 42.9
| TSI | 14.7 | 51.0 | 34.3
| HapMapRevision=28
}}{{omim
|desc=PSORIASIS SUSCEPTIBILITY 11; PSORS11
|id=612599
|rsnum=7709212
}}

{{PMID Auto
|PMID=17236132
|Title=A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=19956104
|Title=Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.
|OA=1
}}

{{PMID Auto
|PMID=20217072
|Title=SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}